Hologic stock soars after Blackstone, TPG reportedly revive takeover interest

Published 17/09/2025, 21:28
© Reuters.

Investing.com -- Hologic Inc (NASDAQ:HOLX) stock closed 7.7% higher after Bloomberg reported that Blackstone Inc. and TPG Inc. have renewed their interest in acquiring the medical device maker.

The investment firms have recently re-engaged with Hologic’s board about a potential takeover and are currently conducting due diligence, according to Bloomberg, citing people familiar with the matter. This renewed interest comes after the Financial Times reported in May that Blackstone and TPG had approached Hologic with an offer exceeding $16 billion, which was rejected at the time.

Hologic had a market capitalization of approximately $14.7 billion before this latest news emerged. Despite today’s significant gains, the company’s stock remains down 16.8% over the past 12 months.

Sources indicate that discussions are ongoing, though any potential deal is still weeks away and there’s no certainty the talks will result in a transaction. Neither Hologic nor the investment firms have publicly commented on the renewed takeover interest.

The medical device maker, known for its diagnostic, surgical and imaging products focused on women’s health, has become an attractive acquisition target amid its recent stock performance challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.